Description
EO14042 | BLOOD COMPATIBILITY TESTING
First action · last action
2023-08-25 · 2024-08-01
Transactions
3
First transaction's obligation
$564,486
Base + all options value (sum of deltas)
$423,365
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C24818D0169
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-08-25+$564,486= $564,486
- Mod P000012024-05-22-$48,415= $516,072
- Mod P000022024-08-01-$92,707= $423,365
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-08-25 | +$564,486 | $564,486 | EO14042 | BLOOD COMPATIBILITY TESTING |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-05-22 | −$48,415 | $516,072 | EO14042 | BLOOD COMPATIBILITY TESTING |
| Mod P00002· FUNDING ONLY ACTION | 2024-08-01 | −$92,707 | $423,365 | EO14042 | BLOOD COMPATIBILITY TESTING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SX3XGHRJMNQ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826N0419 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $792,973 | FY2026 |
| 36C24826N0399 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6506 · BLOOD AND BLOOD PRODUCTS | $354,763 | FY2026 |
| 36C24826N0424 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $268,659 | FY2026 |
| 36C24826N0400 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $314,881 | FY2026 |
| 36C24826N0347 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $619,287 | FY2026 |
| 36C24826D0015 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under Q515 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826P0929 | MEDIALAB SOLUTIONS LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $41,253 | FY2026 |
| 36C24826N0318 | A-TEAM SOLUTIONS LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $1,473,204 | FY2026 |
| 36C24825N0380 | AMERICAN NATIONAL RED CROSS, THE | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $140,007 | FY2025 |
| 36C24825N0285 | A-TEAM SOLUTIONS LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $1,248,041 | FY2025 |
| 36C24824N0320 | A-TEAM SOLUTIONS LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $953,480 | FY2024 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24823N1014_3600_36C24818D0169_3600 · retrieved 2026-09-26.